国产在线拍偷自揄拍无码,欧美成人精品高清在线观看,又粗又黄又爽视频免费看,亚洲精品一区二区久久

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

亚洲av中文无码乱人伦在线咪咕| 亚洲av无码一区二区三区系列| 国产女人乱子对白AV片| 久久亚洲国产成人影院| 国产精品人妻久久久久| 一女被二男吃奶a片免费观看| 中华姓氏起源一览图| 国产成人精品热玖玖玖| 巨胸喷奶水视频WWW免费网站| 波多野结衣 美乳人妻| 国产精品白丝久久AV网站| 男人自慰泄欲飞机gay2022| 狂猛欧美激情性xxxx大豆行情| 国产后入又长又硬| 性色AV无码久久一区二区三区| 人交CZ00与女性XXX| 97精品超碰一区二区三区| 岳女四人共侍一夫婷婷| 亚洲精品无码高潮喷水a片| 亚洲精品久久久久久久蜜桃| 久久精品麻豆日日躁夜夜躁妓女| 欧洲无码精品A码无人区| 高h喷水荡肉自慰爽文np| 精品欧美一区二区三区久久久| 3d漫画全彩我的熟妇老师| 久久av无码精品人妻糸列| 巨茎人妖自慰出精| 边摸边吃奶边做爽免费视频99| 国精无码欧精品亚洲一区| 日韩欧美一中文字暮专区| 成人区人妻精品一区二区不卡网站 | 久久精品国产www456c0m| 六十路垂乳熟年交尾 | 亚洲欧美国产毛片在线| 亚洲国产av一区二区三区四区| 国精品无码人妻一区二区三区| 亚洲AV无码专区在线观看成人| 公交车被cao得合不拢腿视频| 久久久亚洲一区二区三区| 99re8在这里只有精品2| 亚洲精品午夜无码专区|